May 17, 2013
Program in Reproductive and Adult Endocrinology (PRAE), Division of Intramural Research (DIR), NICHD
Masur Auditorium, Clinical Research Center (Building 10), NIH Main Campus, Bethesda, Maryland
The Roy Hertz Memorial Research Symposium commemorates the research and scientific contributions of Dr. Roy Hertz, former NICHD Scientific Director, and a pioneer in the fields of clinical research and women’s health.
The first annual Roy Hertz Memorial Lecture will feature Dr. Ferid Murad, who received the Nobel Prize in Physiology or Medicine in 1998 for his work with nitric oxide, a colorless odorless gas that signals blood vessels to relax and widen, which in turn lowers blood pressure. Dr. Murad will speak about nitric oxide and cyclic guanosine monophosphate in cell signaling and their role in drug development.
The Symposium will also include presentations about health care and a panel discussion about community-based participatory research.
Dr. Hertz accomplished a great deal during his tenure at the NICHD and the NIH. He not only established the first functioning clinical research unit at the NIH, but he also developed the first successful treatment for choriocarcinoma, a cancer of the placenta. This discovery provided the first scientific proof that chemotherapy could cure metastatic cancer, and that a typically fatal cancer in young women could be treated with a single therapeutic agent. Dr. Hertz received an Albert Lasker Award for Clinical Research for the discovery. In his later work, Dr. Hertz developed synthetic forms of the hormone progestin, which later became the basis for the development of oral contraceptives.
This symposium is free and open to the public. Individuals with disabilities who need sign language interpreters and/or reasonable accommodations to participate should contact Marilyn Minor (see below) or the Federal TTY Relay Number (1-800-877-8339). Please make your requests at least 5 days in advance of the event.
Symposium Agenda (PDF - 580 KB)
Marilyn Minor, PRAE, DIR, NICHD